Close Menu

Grants

Additional funding opportunities

Research Funding Opportunities

Tools to Find Funding

Grants Awarded for Health Sciences Research

Title Typesort descending $ Amount Activity Investigator Unit Sponsor Date
Enhanced Mitochondrial Function to Increase Effectiveness of Post-Stroke Rehabilitation (IPA for Helena Morrison) Contract $37,164.14 Research Rick Schnellmann Pharmacy Administration United States Department of Veterans Affairs 05/2020
Yuma County Contact Tracing Contract $252,435.00 Other Sponsored Activity Cecilia Rosales Public Hlth Pract & Trans Rsch Yuma County Public Health Services District 07/2020
Octagam 10% Gam10-09 Study Contract $64,539.00 Research Sydney Rice Pediatrics Octapharma AG 03/2020
In Vivo Screening of Candidate Therapeutic Antibodies in Preclinical Models of Chorioamnionitis-Related Prematurity (ChorP) and Pulmonary Hypertension (PH) Contract $31,026.00 Research Mohamed Ahmed Pediatrics Aqualung Therapeutics, Corp. 02/2020
Epigenetic Evaluation of WUI Firefighters Contract $380,478.00 Research Jefferey Burgess Community Environment & Policy Bureau Veritas North America 05/2020
Salary support for Amani Morgan Mikail Contract $119,988.00 Other Sponsored Activity Madhan Shanmugasundaram Sarver Heart Center Biomedical Research and Education Foundation of Southern Arizona 01/2020
The Crucial Role of HCN2 Channels in Inflammatory and Neuropathic Pain Contract $54,277.03 Research Rajesh Khanna Pharmacology Fondazione Cariplo (Italy) 04/2020
P-glycoprotein Mediated Transport of CNS Therapeutics at the Blood-Brain Barrier Contract $34,128.00 Research Patrick Ronaldson Pharmacology MapLight Therapeutics, Inc. 03/2020
In Vivo Screening of Candidate Therapeutic Antibodies in Preclinical Models of Prostate Cancer Contract $31,231.00 Research Anne Cress Cellular & Molecular Medicine Aqualung Therapeutics, Corp. 02/2020
A Phase 1 Open-Label, Multicenter Study to Evaluate Biomarkers for ZN-c5 in Subjects with Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Contract $91,617.50 Clinical Trial Pavani Chalasani Cancer Center Division Zeno Pharmaceuticals, Inc. 01/2020
MHC Class II Presentation in Melanoma: Impact on Immune Recognition Contract $250,000.00 Research Karen Hastings COM Phx Basic Medical Sci University of Arizona Foundation 08/2020
Influenza Vaccine Effectiveness for Preventing Laboratory-Confirmed Severe Influenza Associated Illness in US Children Contract $44,500.00 Research Mary Gaspers Pediatrics Boston Children's Hospital 05/2020
A Phase 1, Open-label Study of ASP9801, an Oncolytic Virus, Administered by Intratumoral Injection in Patients with Advanced/Metastatic Solid Tumors Contract $458,027.74 Clinical Trial Hani Babiker Cancer Center Division Parexel International Corporation 01/2020
Understanding the Patient-Centered Outcomes for One-stage and Two-stage Brachial Basilic Arteriovenous Fistulas: A Pilot Trial Contract $25,000.00 Research Tze-Woei Tan Surgery American Society of Diagnostic and Interventional Nephrology 04/2020
A Phase 2, Double-Blind, Placebo-Controlled Study to Evaluate the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Relationships of Different Doses.... Contract $273,767.50 Clinical Trial Cori Daines Asthma/Airway Disease Rsch Ctr Janssen Research & Development, LLC 01/2020
A Multi-Center, Adaptive, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome (ARDS.. Contract $168,927.92 Clinical Trial Marilyn Glassberg Csete COM Phx Internal Medicine Kinevant Sciences, Inc. 08/2020
Accuracy of Arthroscopic vs. Open Reduction of Ankle Syndesmosis Injuries Contract $5,000.00 Research Training Aditya Manoharan Orthopaedic Surgery Orthopaedic Research and Education Foundation 04/2020
Octapharma's Octagam 10% Gam10-09 Study Contract $64,944.00 Research Michael Daines Asthma/Airway Disease Rsch Ctr Octapharma Pharmazeutika Produktionsgesellschaft mbH (Austria) 08/2020
A Phase 2, Multi-Center, Open-Label Study to Evaluate Long-term Safety and Efficacy of CXA-10 in Subjects with Pulmonary Arterial Hypertension on Stable Background Therapy: Extension to Study CXA-10-3 Contract $80,418.76 Clinical Trial Franz Rischard Medicine Complexa, Inc. 01/2020
A Phase II, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Biological Activity, and PK of ND-L02-s0201 in Subjects with Idiopathic Pulmonary Fibrosis (IPF) Contract $607,532.16 Clinical Trial Sachin Chaudhary Medicine Covance, Incorporated 08/2020
Animal Purchasing and Husbandry Service Agreement in Support of Protocol 19-3178 "5-HT1F Receptor Agonism as a Novel Therapeutic Strategy Following Spinal Cord Injury" Contract $75,449.72 Research Rick Schnellmann Pharmacy Administration United States Department of Veterans Affairs 07/2020
SAVAHCS: IPA for Josh Crossman Contract $41,154.48 Research Rick Schnellmann Pharmacy Administration United States Department of Veterans Affairs 02/2020
Prenatal Coordinated Care Pilot Program Contract $8,426.00 Research Maria Manriquez-Sanchez COM Phx Obstetrics&Gynecology Superior Court of Arizona in Maricopa County 08/2020
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate The Efficacy and Safety of Anamorelin HCL for the Treatment OF Malignancy Associated Weight Loss and Anorexia... Contract $42,626.00 Clinical Trial Charles Hsu Cancer Center Division PSI Pharma Support America, Incorporated 01/2020
A Phase III, Randomised, Double-blind, Placebo-controlled, Multi-center, International Study of Durvalumab Following Stereotactic Body Radiation Therapy (SBRT) for the Treatment of Patients with... Contract $1,278,228.50 Clinical Trial Charles Hsu Radiation Oncology Astrazeneca 08/2020

Pages